Kanaka eml4-alk fusion gene gu susion

Ua hoʻohanaʻia kēia kī eʻike i nāʻano he 12 mutation mauʻano o nā mea maʻi eml4-alk i nā mea maʻi maʻi counter cunge cance. ʻO nā hopena hōʻike no ka hōʻikeʻana i keʻano o ka hoʻokeleʻana aʻaʻole pono e hoʻohanaʻia e like me ke kumu hoʻokahi no ka mālama pilikino. Pono nā poʻe hoʻokele e hana i nā hoʻoponopono kūlike ma nā hopena hōʻike e pili ana i nā mea e like me keʻano o ka mea maʻi, nā'ōlelo hōʻike lāʻau lapaʻau, a me nā hōʻike hōʻike lāʻau lapaʻau. ʻO ka pōʻino o lung ka mea nui loa i ka honua, a me 80% ~ 85% o nā hihia he mea liʻiliʻi liʻiliʻi (nsclc). ʻO ka fusion o ka cusion o echinderm micututubule-e pili ana i ka folin-like 4 (eml4) a me ka alk) ma keʻano he herclc. miliona miliona mau helu helu. Ma kahi o 20 mau mea hana e loaʻa ai nā mea likeʻole, ma waena o ka 12 Fusion Mika 33% a me 29% o nā mea maʻi me nā maʻi eml4-alk fusion gen nusclc, kūpono loa. Ua hōʻikeʻiaʻo Alk Toohiboror e CIIHITINIBIB i nā lāʻau liʻiliʻi-molecle i hoʻolālāʻia no nā lāʻau lapaʻau i hoʻokumuʻia no ka alk gion gounations. I ka hoʻopauʻana i ka hana o ka Alk Tyrostine Kinase Kinase, e kāohi ana i kona mau wahi e hele nei, e hoʻokō ai i ka lāʻau lapaʻau no nā'ōpala. Ua hōʻikeʻia nā haʻawina Clinical i hōʻikeʻiaʻo CIIZITIIB i kahi helu o ka 61% ma nā mea maʻi eml4-alk Fusivalication No laila,ʻo kaʻikeʻana o ka mikaʻO EML4-Alk Fusion ke kumana a me ke kumu no ke alakaʻiʻana i ka hoʻohanaʻana i nā lāʻau lapaʻau.